Gruppa LSR PAO (LSRG)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 528.40 |
|---|---|
| 52-week range | 468.00 – 745.20 |
| Return, 1 month / 3 months | +3.6% / +1.6% |
| Return, 1 year / 3 years | −28.0% / −14.8% |
| Trend | Below its 200-day average |
| RSI (14) | 61 |
| Volatility (1 year) | 29.9% |
| Worst drawdown (1 year) | -35.5% |
| Average daily value traded | 35.44M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gruppa LSR is a Russian property developer that builds residential housing, chiefly large-panel apartment buildings, for homebuyers in cities such as Saint Petersburg and Moscow. Alongside development, the company produces building materials, including bricks and cement, and carries out construction work for its own projects. It is based in Saint Petersburg and serves mainly private buyers of apartments together with commercial customers for its construction products.
Gruppa LSR PAO trades under the code LSRG on the Moscow Exchange in Russia, with its price quoted in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gruppa LSR PAO (LSRG) trades on the Moscow Exchange in Russia. It last closed at RUB 528.40 on 19 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 126 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 28.0% and over the last three months it rose 1.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.4% | ||
| From 52-week high | -27.7% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.6% | ||
| 6-month return | -20.3% | ||
| 12-month return, skipping the last month | -30.5% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.5% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 35.44M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +3.6% |
| 3 months | +1.6% |
| 6 months | −20.3% |
| 1 year | −28.0% |
| 3 years | −14.8% |
| 5 years | −5.2% |
Signals
| 50-day / 200-day average | 511.88 / 610.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2024 | RUB 78.0000 |
| 7 Jul 2023 | RUB 78.0000 |
| 11 May 2023 | RUB 39.0000 |
| 11 May 2021 | RUB 39.0000 |
| 12 Oct 2020 | RUB 20.0000 |
| 12 May 2020 | RUB 30.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.